African Potato (Hypoxis hemerocallidea)
African potato (Hypoxis hemerocallidea) contains hypoxoside and rooperol as primary bioactive compounds that exhibit immunomodulatory and antioxidant effects. Clinical studies demonstrate potential immune support in HIV patients without interfering with antiretroviral therapy.

Origin & History
African potato (Hypoxis hemerocallidea) is a perennial herbaceous plant native to southern Africa, particularly South Africa, where its corm (underground stem) is harvested for medicinal use. The active compounds are typically extracted through decoction, alcohol extraction, or processed into tablets standardized to hypoxoside content.
Historical & Cultural Context
African potato has been used for centuries in South African traditional medicine, particularly within the Zulu healing system, as an immune booster for HIV/AIDS, tuberculosis, cancer, and infections. It remains widely self-administered by HIV patients in southern Africa for immune enhancement.
Health Benefits
• Potential immune support in HIV patients - preliminary evidence from small safety studies (n=16-20) shows tolerability with antiretroviral therapy • No drug interactions with HIV medications - clinical trials show no alterations in efavirenz or lopinavir/ritonavir pharmacokinetics • Antioxidant properties - in vitro studies link hypoxoside to antioxidant activity • Traditional use for infections - centuries of use in Zulu medicine, though lacking modern clinical validation • Possible blood sugar support - preclinical animal studies suggest antihyperglycemic effects, no human data
How It Works
African potato's hypoxoside converts to rooperol through β-glucosidase activity, providing antioxidant effects by scavenging free radicals and reducing oxidative stress. Rooperol modulates immune function through cytokine regulation and may enhance T-cell activity. The compounds also demonstrate anti-inflammatory properties by inhibiting pro-inflammatory mediators.
Scientific Research
Clinical evidence is limited to small pharmacokinetic interaction studies in healthy volunteers (PMID: 19374071) and a pilot safety study in HIV patients (PMID: 33585170), with no large RCTs or meta-analyses for therapeutic outcomes. The efavirenz interaction study (n=10) and lopinavir/ritonavir study (n=16) found no significant drug interactions, while all trials confirmed short-term safety up to 15 days.
Clinical Summary
Small safety studies (n=16-20) in HIV patients show African potato is well-tolerated alongside antiretroviral therapy. Pharmacokinetic studies confirm no drug interactions with efavirenz or lopinavir/ritonavir combinations. Preliminary evidence suggests immune support benefits, though larger controlled trials are needed. Current research focuses primarily on safety rather than efficacy outcomes.
Nutritional Profile
African Potato (Hypoxis hemerocallidea) corm contains bioactive compounds as primary constituents rather than conventional macronutrients as a medicinal plant. Key documented compounds include: Hypoxoside (the principal bioactive norvlignan glycoside, present at approximately 0.1–1.5% dry weight of corm), which is hydrolyzed in the gut to its aglycone rooperol — the pharmacologically active antioxidant metabolite. Sterols are a major class: beta-sitosterol, beta-sitosterol glucoside (sitolin), stigmasterol, and campesterol are present at combined concentrations estimated at 0.3–0.8% dry weight; beta-sitosterol is the most studied and linked to immunomodulatory and potential anti-inflammatory effects. Phytosterol content is notably high relative to most plant foods. The corm contains moderate starch-based carbohydrates as structural tissue (rough estimate 40–60% dry weight as would be typical of corm material), though precise macronutrient breakdowns from controlled nutritional analysis are not widely published in peer-reviewed literature. Crude fiber content is present but not precisely quantified in available literature. Trace mineral content includes iron, calcium, and potassium, consistent with sub-Saharan root vegetables, but specific concentrations lack standardized published data. Phenolic compounds beyond hypoxoside contribute to overall antioxidant capacity measured in vitro. Bioavailability note: Hypoxoside itself has poor direct bioavailability; colonic bacterial hydrolysis to rooperol is required for activity, meaning gut microbiome composition significantly influences pharmacological effect. Commercial preparations vary widely in hypoxoside standardization, making dose-response extrapolation difficult.
Preparation & Dosage
Clinically studied doses include 15 mg/kg hypoxoside daily as decoction or extract for 7-15 days. Hypoxoside tablets were used over 10 days in safety studies, reaching steady-state based on 20-50 hour half-lives. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Echinacea, Astragalus, Reishi mushroom, Vitamin C, Zinc
Safety & Interactions
African potato appears safe when used with HIV medications based on clinical studies showing no pharmacokinetic interactions. Common side effects are mild and may include gastrointestinal upset. Safety during pregnancy and breastfeeding has not been established. Patients should consult healthcare providers before combining with other immunomodulating supplements or medications.